Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03413423 · ClinicalTrials.gov registry record · NA
Post Acute Cardiac Event Smoking (PACES) Study
A NA study of Tobacco Use and Acute Coronary Syndrome, sponsored by Hennepin Healthcare Research Institute.
- Active
- Registry status
- NA
- Development phase
- 233
- Enrollment target
- 1
- Study location
NCT03413423 is a NA study of Tobacco Use and Acute Coronary Syndrome that is active but no longer recruiting, run by Hennepin Healthcare Research Institute. The registered enrollment target is 233 participants, below the 376-participant average among 76 other Tobacco Use trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03413423, a NA study of Tobacco Use and Acute Coronary Syndrome, is active but no longer recruiting, sponsored by Hennepin Healthcare Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 233 participants
- Enrollment target
- 1
- Study location
Study Summary
Summary of the Project : Quitting smoking following acute coronary syndrome (ACS) can reduce mortality up to 50%. However, depression and smoking are highly co-morbid and depressed mood may interfere with cessation and independently predicts mortality. Thus, a single, integrated treatment for both smoking and depression could be highly effective in reducing post-acute coronary syndrome mortality. Behavioral Activation (BA) is a well established treatment for depression and has recently shown promise as a treatment for smoking cessation. The investigators systematically developed an intervention integrating gold standard smoking cessation counseling with existing BA based mood management techniques for post-ACS smokers; Behavioral Activation Treatment for Cardiac Smokers (BAT-CS). Objective: For this R01 the investigators will evaluate the efficacy of using a single, integrated treatment that targets both depressed mood and smoking (BAT-CS).
Conditions Studied
Interventions
- BEHAVIORAL BAT-CS
- BEHAVIORAL Smoking Cessation and Health & Wellness
Study Locations (1)
Minnesota
- Hennepin County Medical Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2018-01-29 |
| Est. Completion | 2026-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03413423
The ClinicalTrials.gov registry entry for NCT03413423 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 233 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 76 other Tobacco Use trials with a reported enrollment target (38% lower). The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which BAT-CS is the first listed.
NCT03413423 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03413423 about?
NCT03413423 is a clinical study titled "Post Acute Cardiac Event Smoking (PACES) Study". Summary of the Project : Quitting smoking following acute coronary syndrome (ACS) can reduce mortality up to 50%. However, depression and smoking are highly co-morbid and depressed mood may interfere with cessation and independently predicts mortality. Thus, a single, integrated treatment for both ...
What is the current status of trial NCT03413423?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 233 participants. The study started on 2018-01-29. Estimated completion is 2026-05-30.
What conditions does trial NCT03413423 study?
This clinical trial studies the following conditions: Tobacco Use, Acute Coronary Syndrome.
What interventions are being tested in trial NCT03413423?
The interventions under investigation include: BAT-CS (BEHAVIORAL), Smoking Cessation and Health & Wellness (BEHAVIORAL).
Who is sponsoring clinical trial NCT03413423?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03413423 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.